Study offers hope to pregnant women with HIV

11/6/2007 | France 24

Adding single doses of tenofovir and emtricitabine to the standard single dose niverapine to treat HIV-infected women during labor reduces resistance to non-nucleoside reverse transcriptase inhibitor drugs, a new study found. By reducing the maternal niverapine resistance, it becomes possible to treat HIV-infected babies with commonly used medications.

View Full Article in:

France 24

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Assistant General Counsel, Regulatory
Cardinal Health
Waukegan, IL
Chief Executive Officer
UCare Minnesota
Minneapolis, MN